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Abstract Hair can be engineered at different levels—its structure and surface—
through modification of its constituent molecules, in particular proteins, but also
the hair follicle (HF) can be genetically altered, in particular with the advent of
siRNA-based applications. General aspects of hair biology are reviewed, as well as
the most recent contributions to understanding hair pigmentation and the regula-
tion of hair development. Focus will also be placed on the techniques developed
specifically for delivering compounds of varying chemical nature to the HF,
indicating methods for genetic/biochemical modulation of HF components for the
treatment of hair diseases. Finally, hair fiber structure and chemical characteristics
will be discussed as targets for keratin surface functionalization.
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1 Structure and Morphology of Human Hair
Human hair is mainly composed of fibrous a-keratin proteins. Hair fibres are not
continuous in their full length, but rather result from compact groups of cells
within the fibre follicle, from which three further basic morphological components
of hair structure originate: the multicellular cuticle sheath, the fibrous cortex and
the medulla [1, 2].
At the follicular level, a single layer of cells gives rise to the cuticle, a pro-
tective layer covering the core of the fibres. It is mainly composed of b-keratins
and displays a scaled structure, possessing between seven and ten superimposed
layers with the cuticle edges pointing toward the tip of the fibre [3]. The outer
surface of the culticle’s scale cells is coated by a thin membrane called the epi-
cuticle, which covers the cysteine-rich exocuticle, a constituent that contains most
of the cysteine residues present in the scales [4]. Finally, there is the endocuticle,
which is located at the interface of the cortex and is mainly composed of the
remaining cell organelles. Endocuticle consists of proteins that, unlike those found
in other parts of the hair fibre, have very low sulphur content; thus, it is poor in
cysteine, which causes the endocuticle of the scales to swell considerably more in
water than the cysteine-rich exocuticle. This might explain the pronounced pro-
jection of the scales and the tendency for wool felting in the presence of water [5].
The cuticle tightly encircles the cortex that forms the most voluminous part and
the heart of the hair fibre. The cortex is made up of cortical cells, which comprise
the macrofibrils, long filaments oriented parallel to the axis of the fibre. Each
macrofibril consists of intermediate filaments (IF), known also as microfibrils, and
the matrix [6, 7]. It has been established that the molecules that aggregate to form
the IFs in keratin fibres are type I and type II keratin chains, arranged parallel to
one another and in the axial register. After the formation of the a-helices, it is
believed that the two types of chains associate to form a dimer, which then
aggregates with another dimer to form a tetramer. Finally, the formation of a
pseudo-hexagonal structure (the IFs structure) occurs by the association of seven
or eight tetramers. Type I chains are net acidic, with pI values in the range of
4.5–5.5, while type II chains are neutral-basic with pI around 6.5–7.5 [8–11]. As a
consequence, the IFs are low in cystine (*6%), whereas the matrix contains up to
20% of total amino acid residues [12–14].
The matrix proteins that surround the IFs through intermolecular disulfide
bonds act as a disulfide crosslinker holding the cortical superstructure together and
conferring high mechanical strength, inertness and rigidity to keratin fibres. High
sulphur proteins, ultra-high sulphur proteins and high glycine-tyrosine proteins are
present in matrix proteins (c-keratins), depending on their cysteine, tyrosine and
glycine content [1, 4, 15, 16].
Apart from albinos, all normal humans have melanin hair pigmentation,
whatever the colour. Dispersed throughout the structure of the cortex in granular
form are the melanin pigment particles. The number, chemical characteristics and
distribution pattern of these cells determine the colour of the hair [2]. The actual
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shade of colour in each individual depends not only on which melanin is present,
but also its quantity and the site, number and shape of pigment granules in the hair
cortex (Cx) [17].
Vacuolated cells may also be present along the axis of coarser a-keratin fibres,
forming the medulla. These cells generally constitute only a small percentage of
the mass of hair and are believed to contribute negligibly to the mechanical
properties of human hair fibres. Physically, the medulla forms the empty space of
the fibre [4, 7].
Like all polymeric structures, keratin fibres consist of long, tightly bound
molecular chains held together in many different ways from covalent bonds to
weaker interactions such as hydrogen bonds, Coloumbic interactions, van der
Walls interactions and, when water is present, hydrophobic bonds. Hair reactivity
is complex and depends not only on the presence of reactive groups in the fibre,
but also on their availability. The latter is significantly affected by fibre mor-
phology and molecular structure [2]. Hair is mostly proteinaceous in nature, while
structural lipids and other materials represent only a minor fraction of its
constituents.
Human hair is usually categorised ethnically into three major distinct groups:
Asian, Caucasian and African. Looking from the perspective of biological vari-
ability, environmental effects and diversity of fibre texture, it is remarkable how
uniformly the amino acid makeup of protein components is across ethnic groups.
The amino acid makeup of the protein components was reviewed by Wolfram and
is depicted in Fig. 1 [1, 2, 18, 19].
2 Biology of Human Hair
Hair is an important feature of mammalians, where hair shafts fulfill a number of
different functions such as thermoregulation, collection of sensory information,
protection against environmental trauma, social communication and camouflage.
Each of us displays an estimated total number of 5 million hair follicles (HF), of
which 80,000–150,000 are located on the scalp [20].
Fig. 1 Amino acid content of human hair of diverse ethnic origins (lM/g) (adapted from [1, 2,
18, 19])
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The HF (Fig. 2) is one of the most complex mini-organs of the human body
with the capacity to reconstitute itself. During postnatal life, HFs show patterns of
cyclic activity with periods of active growth and hair production (anagen),
apoptosis-driven involution (catagen) and relative resting (telogen) [21]. These
cyclic changes involve rapid remodeling of both epithelial and dermal components
and suggest the presence of intrinsic stem cells. Stem cells isolated from the bulge
area possess high proliferative potential in vitro [22] and the capacity to repopulate
HFs, sebaceous glands and epidermis in vivo [23–27]. These transformations are
Fig. 2 The human hair follicle: structure, main functional areas and concentrical layers, which
constitute the typical hair
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regulated by variations in the local milieu, based on changes in expression and/or
activity of many cytokines, hormones, enzymes, neurotransmitters and their cog-
nate receptors as well as of transcription factors that have become recognised as
key mediators of HF cycling.
2.1 Hair Follicle Anatomy
The HF results of interactions between epithelial, mesenchymal and neuroecto-
dermal cell populations as well as transient migratory cells.
The epithelium is divided into an upper permanent region, distal to the arrector
pili muscle and an inferior region that includes the hair bulb (Fig. 2) [28]. Each HF
is composed of nine distinctive epidermal layers: hair matrix (Mx), medulla (M),
Cx, hair cuticle (Ce), cuticle of the inner root sheath (Ci), Huxley’s layer (Hx),
Henle’s layer (He), companion layer (Cp) and outer root sheath (ORS), arranged
concentrically from core to periphery, as well as two dermal tissues: dermal papilla
(DP) and dermal sheath. Among these tissues, only the medulla is optional, given
that some hairs have no medulla, whereas in others it is relatively large. The Cx
and Ce constitute the major part of the hair shaft that penetrates the skin. Both Cx
and Ce tissues undergo heavy keratinization to form the solid hair shaft. The three
concentric layers located externally to the shaft constitute the inner root sheath
(IRS), which is thought to support the growth and differentiation of the shaft. The
innermost layer of the IRS, called the Ci, consists of thin overlapping scales facing
the Ce. The Hx layer is the last layer to undergo keratinization. This layer may
help other keratinized cells in terms of nutritional and informational support.
Importantly, Hx is known to contribute to relieving the distortion caused by
uneven keratinization of the shaft, which occurs in curly hair, for example. On the
other hand, the He layer keratinizes at a very early phase of hair growth so these
keratinized cells are visible at a positionally low level of the HF. He layer provides
mechanical support to the most delicate part of the HF in the early stages of its
development.
Located within the hair bulb is a population of cells with the highest prolif-
eration rate in the human body: the keratinocytes of the Mx. These can differ-
entiate into trichocytes or cells of the IRS. The hair bulb in the anagen phase
functions as a hair shaft producer and provides the hair shaft’s trichocytes with
characteristic melanin granules. The ORS, Mx and hair shaft derive from the
epithelial bulge stem cells [24, 25, 27].
Mesenchymal stem cells in the tissue sheath serve as a reservoir for new DP
cells. The DP determines the size of the anagen hair bulb, the duration of anagen
and hair shaft diameter [20, 29, 30]. In adult hair, DP maintains the vascular
system that provides the nutritional support and hormonal regulation required for
hair growth [31].
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2.2 Hair Follicle Morphogenesis
Follicle morphogenesis regularly occurs only during embryonic development, so
each mammal is born with a fixed number of follicles that normally does not
increase afterwards, although folliculoneogenesis can take place during wound
healing [32–34].
2.2.1 Hair Follicle Life Cycle
The hair growth cycle describes the changing histological morphology of the shaft
and of the follicle over time. Starting with anagen (rapid growth and hair shaft
elongation), the follicle and its shaft progress through catagen (involution and
apoptosis-driven regression), telogen (resting) and finally exogen (shedding) [20,
21, 35].
In anagen, the growth phase of the hair cycle, hair undergoes morphological
and molecular events similar to fetal HF morphogenesis [36, 37]. Many key
molecular regulators of hair biology not only activate morphogenesis, but also
regulate anagen induction and duration [38, 39]. In this phase, epithelial bulge
stem cells differentiate into the various cell types that will reconstitute the entire
hair shaft [40, 41]. Hair shaft synthesis and melanin production in melanocytes
(melanogenesis) [42], only take place in anagen. Pigmentation begins after the
initiation of shaft formation and ends before this process is terminated, which
causes the shaft to have an unpigmented tip and root. By the 7th week of gestation,
melanocytes are already present in the human epidermis where they remain until
hair morphogenesis starts, approximately 2 weeks later [43]. During HF mor-
phogenesis, a few melanoblasts leave the epidermis and distribute randomly in the
forming HF and in some sebaceous glands [44, 45]. Once the hair fiber is com-
pletely formed, melanocytes concentrate near the basal lamina surrounding the DP
[44]. Anagen ends with a tightly regulated involution of the HF, which is
accompanied with apoptosis and terminal differentiation of cells, a period desig-
nated as catagen [46].
The first sign of catagen is the cessation of melanin production in the hair bulb
and apoptosis of follicular melanocytes, derived from melanocytic stem cells of
the secondary hair germ [47]. Programmed cell death of these stem cells seems to
play an important role in hair graying [48–50]. In contrast to what happens in the
ORS and the Mx, no apoptosis occurs in the DP due to the presence of antiapo-
ptotic protein BCL-2 [37, 46]. During catagen, the DP condenses, moves upward
beneath the HF bulge and halts its activity.
After regression, the HF enters telogen, a phase of relative quiescence regarding
proliferation and biochemical activity. The follicle remains in this stage until it is
reactivated by intra- and extrafollicular signals [51].
Once the growth cycle is complete and the phase of telogen reaches the end, the
hair shaft will be shed. This process, exogen or teloptosis, is independent of a
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possible new HF cycle [52]. In fact, it is most common in mammals that a new hair
shaft regrows before the resting shaft sheds, assuring the animal is never com-
pletely naked. Apart from normal development, in pathologies like trichostasis,
where multiple shafts are formed and retained within the same HF, it also supports
the thesis that follicle growth and shedding are independent events. Exogen ends
when the shaft is released.
Recently, Rebora and Guarrera used the term kenogen to describe the interval
in which the HF remains empty after the telogen hair has been shed and before a
new anagen hair emerges. During kenogen the HF remains completely empty and
possibly inactive. Frequency and duration of kenogen are greater in men and
women with androgenic alopecia [53].
All body hairs undergo a similar life cycle, although its extent, the duration of
its phases and the length of individual shafts vary between different body areas and
between individuals, depending on genetic programming, genre, age and health
status.
2.3 Molecular Control of Hair Follicle
Development and Cycling
Epithelial-mesenchymal interactions are crucial in HF development and cycling.
During normal embryonic development, interactions between epidermal kerati-
nocytes and DP fibroblasts lead to the formation of the hair shaft. The most
important factors regulating both developing and anagen follicles include the
lymphoid-enhancer factor 1 (Lef1), Notch signaling pathway, Sonic hedgehog
(Shh), bone morphogenetic proteins (BMPs), neurotrophins and several members
of the Wnt family of proteins.
Bone morphogenetic proteins are expressed during embryonic development and
postnatal life of nearly all mammalian organisms and play important roles in the
regulation of both cell proliferation and differentiation [54]. BMP signaling
inhibits induction of follicle development [35], and the neutralization of BMP-2
and BMP-4 activity by noggin stimulates the initiation of HF development
[55, 56]. However, the differentiation of keratinocytes into mature and cuticle cells
is severely impaired if levels of BMPs decrease as these proteins restrict the
proliferating population to the bulb region [57]. Recent studies reinforce the
important role that the BMP signaling network plays in the development and
homeostasis of HF structure through the activation and/or maintenance of stem cell
populations [58, 59].
The Wnt signaling pathway has been implicated in multiple cellular events
including the regulation of cell proliferation, cell fate, polarity, differentiation and
pattern formation [60, 61]. Wnts are divided at least into three groups according to
their signal transduction pathways: the canonical pathway in which b-catenin
stabilization occurs, the planar cell polarity (PCP) pathway and the Wnt/Ca2+
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pathway [62]. Canonical Wnt/b-catenin signaling plays an important role in HF
induction and fate [63–69], and expression of several Wnts, Wnt ligands and
inhibitors is specifically elevated in developing and postnatal HFs [61, 70–72]. On
the other hand, forced activation of b-catenin signaling promotes HF fate in both
embryonic and postnatal skin [67, 73–75]. Recent studies also suggest that another
pathway, the ectodysplasin signaling pathway, is critical for the induction and
maintenance of placode [76, 77].
In a surprising report, Ito and collaborators revealed that HF can form de novo
in adult mice after wounding [33], contrary to the belief that follicle neogenesis
only occurred during embryonic development. This phenomenon is completely
dependent on Wnt signaling, and overexpressing Wnt actually increases the
number of HF formed. Interestingly, the cells forming the new HF originate in the
re-epithelialized interfollicular epidermis and not follicle stem cells.
In vertebrates, Shh is a member of the hedgehog (Hh) family of secreted
signaling molecules that play a crucial role in both embryogenesis and organo-
genesis [78, 79]. Shh is required for HF morphogenesis during embryogenesis and
for regulating follicular growth and cycling in the adult. HF formation may start
without Shh, but mature HFs fail to develop because hair germs cannot elongate
into the dermis to form a hair peg and the DP does not mature [80–82]. In postnatal
skin, Shh is relevant for hair cycling, its expression being up-regulated in early
anagen. In line with this, treatment with Shh-blocking antibodies is known to cause
reversible alopecia, as HF cannot cycle and arrest in telogen [83]. On the other
hand, exogenous Hh stimulates the transition from resting (telogen) to growth
(anagen) stage [84] and, in some settings, anticipates the start of anagen and
promotes hair regrowth in the skin of mice with chemotherapy-induced alopecia
[85, 86]. These studies indicate a potential application of Hh modulation in control
of hair density.
The Notch signaling pathway is also important for determining cell fate in HF
development [87]. Notch signaling acts by blocking cell differentiation, which
maintains the competence of undifferentiated cells [88, 89] in both the developing
tooth and the HF to respond to inductive signals that determine their develop-
mental fate [87, 90]. Based on expression studies in the HF, Notch may be a
competence factor, as its pattern of expression in the HF appears to be restricted to
cells that have left the proliferative pool but have yet to terminally differentiate
[91, 92].
Although Notch activation is not required for HF formation in the embryo,
blocking Notch signaling in postnatal epidermis results in conversion of HF into
interfollicular epidermal cysts. In the absence of Notch signaling, the hair shaft
still forms and contains appropriately positioned cells expressing markers for each
fate; however, because IRS cells fail to adhere to each other, the follicular
architecture cannot be sustained, which leads to the transformation of these
aberrant HF into epidermal cysts [92–95]. Very recently, Demehri and Kopan [96]
proposed that Notch acting on bi-potential bulge stem cells, or their uncommitted
migratory descendents, plays an inhibitory role in preventing bulge stem cells from
differentiating into epidermal cells, thus ensuring the follicular fate.
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It was also reported that Notch signaling, via its target gene Hes1, is essential for
the maintenance of melanoblasts and adult melanocyte stem cells [97, 98]. More-
over, mice with a conditional deletion of RBP-JR (Notch transcription mediator)
display, soon after birth, impaired hair pigmentation and subsequent progression of
hair graying. Specifically, Notch1 and Notch2 targeted deletion in melanocytes led
to inactivation of the RBP-JR gene in a dose-dependent manner, and three intact
alleles of Notch1 and Notch2 are required for preventing precocious hair graying
[98]. Notch 3 and 4 are not implicated in this phenotype [99, 100].
Hormones, particularly androgens, are among the most important, although
non-essential, modulators of hair growth. Androgens have paradoxically different
effects on human HF depending on their body site. Androgens can stimulate hair
growth on the face (beard), axilla, pubis and chest, where they are necessary for
conversion of vellus hair to terminal hair, while they simultaneously can inhibit
HF on parts of the scalp, converting terminal hair to vellus hair, causing balding in
genetically susceptible individuals (for reviews, see [101, 102]).
Androgens, except for pubic and axillary follicles, require the intracellular
enzyme 5a-reductase to metabolize testosterone to its more potent metabolite 5a-
dihydrotestosterone (DHT). DHT then interacts with intracellular androgen
receptors in the HF cells to modulate target gene transcription. The exact mech-
anism is not fully established, but Randal proposed the DP as the primary target
[103, 104]. In this model, androgens act directly on DP cells where they bind to
androgen receptors and then initiate altered gene expression of regulatory factors
modulating indirectly the period of time when hair is growing, size and activity of
the DP, keratinocytes and melanocytes. The factors produced by these populations
may be soluble paracrine factors and/or extracellular matrix factors, including
insulin-like growth factor-1 (IGF-1) in growth stimulation [105], stem cell fac-
tor in altered pigmentation [102] and transforming growth factor-b [106, 107] and
dickkopf 1 [108] in inhibition. The opposite effects of androgens on beard and
scalp follicles probably reflect differences in androgen receptor content, which is
higher in beard DP than in occipital hair DP [109] and/or 5a-reductase activity,
which is higher in beard than in scalp [110]. Recent observations suggest that the
dermal sheath can also respond to androgens without the DP acting as an inter-
mediary [111].
Several other hormones are implicated in the regulation of the hair growth
cycle, including melatonin, prolactin, melanocyte-stimulating hormone (MSH),
thyroid hormones and oestrogens. Prolactin is implicated in hair growth regulation
in both mice and human [112–114]. Similarly, melatonin has been reported to
promote hair growth in animals and in humans, where topical application of
melatonin induced hair, probably through induction of anagen [115].
Human hair is deeply affected by the level of unbound thyroid hormones that
have been described to prolong the duration of anagen, up-regulate the prolifer-
ation of Mx keratinocytes and also stimulate intrafollicular melanin synthesis [101,
116, 117]. On the other hand, several studies reveal that a significant percentage of
patients presenting hair loss were diagnosed as suffering from hypothyroidism
[118, 119].
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Estrogens, namely 17b-estradiol, act mainly as hair growth inhibitors. Topical
application to mice skin of 17b-estradiol inhibits hair growth and accelerates
catagen, while antiestrogens promote early anagen [120, 121]. A similar inhibitory
effect on hair growth was observed in humans [122, 123]. Nevertheless, the exact
role of estrogens in the regulation of the HF life cycle is still under debate.
Very recently, mammalian circadian clock genes such as Clock and Bmal1
were reported to be involved in the regulation of HF cycling [124], suggesting that
modulation of hair growth may also be achieved by modulating circadian genes
through control of the cell cycle.
Taken together, these studies suggest that the described genes and signaling
pathways regulating HF morphogenesis and cycling can be reactivated and
modulated in adult skin, creating new strategies for hair regeneration.
3 Strategies for Cosmetic and Clinical Purposes
3.1 Treatments of Hair Growth Disorders: Room
for Improvement
The most common types of hair growth disorders are caused by aberrant HF
cycling. One such disorder is androgenetic alopecia, characterized by a shortening
of the anagen phase and a prolongation of telogen, combined with miniaturization
of HF [125]. Hirsutism, on the other hand, is defined as the presence of excess
terminal hairs in females in an adult male typical pattern [126]. To control the
amount of hair produced for clinical purposes, the main strategy is to alter anagen
duration either by shortening it in cases of hirsutism or by increasing it to correct
alopecia.
The first-generation drugs used for hair growth control—topical minoxidil
solution and oral finasteride—are the only FDA-approved drugs for this applica-
tion. Minoxidil prolongs the anagen phase, and promotes growth and enlargement
of follicles in telogen phase [30, 127]. The effects of minoxidil on human HF are
nevertheless very contradictory. Some studies describe that, at low concentrations,
minoxidil stimulates anagen in human follicles [128–130], while it can cause
growth inhibition at high concentrations [128]. Other authors reported no effect at
all [131].
Nevertheless, it is assumed that treatment with minoxidil lengthens and
thickens the small vellus hairs and decreases shedding. Minoxidil is a potassium
channel opener that causes vasorelaxation [132] and stimulates cutaneous blood
flow to the scalp [133]. Minoxidil sulfate, a metabolite of minoxidil, is a potent
vasodilator. Uptake and conversion of minoxidil to minoxidil sulfate occurs within
the HF, suggesting a direct action on the follicle [134]. The most probable site of
action of minoxidil is the DP [135], and the mechanism of action has been linked
to its effects on the Kir6.1/SUR2B potassium channel expressed by the derma
papilla [136–138].
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Finasteride inhibits 5a-reductase type II and decreases both serum and cuta-
neous dihydrotestosterone concentrations, thus inhibiting androgen-dependent
miniaturization of HF [139]. The DP is probably also the target of finasteride. This
drug is not effective in treating androgenetic alopecia in women, but it can be
beneficial for women with hirsutism. Finasteride must be nevertheless used very
cautiously because of its potential feminizing effects on male fetuses [104] and
even in adult male patients where some cases of gynecomastia have been reported
[140].
Latanoprost has also been found to reverse alopecia and induce increased
growth of the eyelashes [141]. A beneficial role in reversing androgenetic alopecia
has not, however, been found, and detailed studies regarding whether latanoprost
or another prostaglandin analog could be clinically used are still lacking.
Additional current pharmacological therapies for hair disorders include a range
of antiandrogens that block the intracellular androgen receptors [142]. The
mechanisms by which all these compounds trigger hair cycle changes are not clear
and justify further studies.
In recent years, the molecular characterization and isolation of living bulge
stem cells along with the studies that revealed their high proliferative capacity and
multipotency opened up new directions for their utilization in cutaneous (hair and
skin) regenerative medicine [24, 25, 143, 144]. This new approach suggests the
control of hair characteristics from the living interior of the fiber. For this purpose,
profound knowledge of genes and signaling pathways involved in hair disorders
will permit specific modulation using, for example, RNA interference. miRNAs,
which play a critical role in skin morphogenesis, were reported to be involved in
the regulation of HFs development and cycling, but neither their expression nor
their roles have been characterized yet [145]. This elucidation is crucial to develop
new efficient treatments for hair disorders that do not cause hair damage or skin
injuries, possibly using RNA interference for highly specific modulation of genes
involved in these processes.
As proof of principle, we have achieved effective siRNA delivery and efficient
modulation of a ubiquitous, highly expressed KRT1 gene in the epidermis of DBA/
2J mice with a topical treatment (Araujo et al., submitted data).
Interestingly, topical application of cationic nanoliposomes loaded with specific
siRNA has been tested as an effective approach for control of cutaneous mela-
nomas [146], and siRNAs conjugated to cationized gelatin showed a positive
effect on symptoms of alopecia in C3H/HeJ mice [147]. A promising line of
research has been developed by Kerner and colleagues that proposes modulating
androgen receptor expression with RNAi for hair and skin therapy [148, 149].
Nevertheless, this is still a very incipient area that promises to bring new and
highly targeted strategies for skin and hair diseases.
HF as well as sweat glands are ideal targets for drug delivery and may represent
an alternative to the intercellular route of skin permeation. HF, in contrast to the
stratum corneum, represent an efficient long-term reservoir (up to 10 days) for
topically applied substances, as their depletion occurs only through the slow
processes of sebum production and hair growth [150–152]. The molecules that
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penetrate HF can also access the tissues surrounding the follicle and reach the
blood circulation through the dense network of blood capillaries, thereby avoiding
the stratum corneum barrier. For example, it was shown that when caffeine was
included in a shampoo formulation, it was detectable in blood just 5 min after
application [153]. Therefore, HF may serve not only as a major entry point, but
also as a reservoir for dermally applied substances. In addition, HF also contained
multiple target structures for innovative therapeutic approaches. These include
specific cell populations in and around the HF, such as immune cells, stem cells
and melanocytes, sebaceous glands and perifollicular blood vessels [154–156].
The sebaceous glands represent an important therapeutic site for follicular
targeting since they are implicated in the aetiology of acne and androgenetic
alopecia [157], as well as in other sebaceous gland dysfunctions [158]. Hueber
et al. [157] suggested that the sebaceous glands specifically promoted the pene-
tration of hydrocortisone and testosterone into the skin. Evidence suggests that
topically applied compounds entrapped in liposomes accumulated not only in the
HF, but also in the sebaceous glands [159]. While the presence of lipophilic sebum
may favor follicular uptake of lipophilic molecules, sebum production may,
however, moderate drug transport, especially for hydrophilic drugs, functioning as
a physical and a chemical barrier for drug penetration [160].
More efficient drug delivery vehicles are therefore being sought. Among the
newly emerging concepts, drug delivery systems based on nano- and microparti-
cles, which efficiently penetrate via the follicular route, are highly promising
approaches. Nanospheres of different chemical natures are being tested for their
capacity to facilitate the transport of substances to deeper layers of the skin, with
obvious potential in topical delivery applications.
Another attractive targeting area within the HF is the bulge region. This region,
including Mx cells, controls hair growth and pigmentation [161] and is responsible
for follicle reconstitution due to the presence of stem cells with a high proliferative
capacity and multipotency. The bulge region, in the ORS, has been described as
the reservoir for keratinocyte stem cells in both humans and rodents [24, 26, 143,
162–164]. These cells are the target for gene delivery to facilitate long-term gene
correction of congenital hair disorders or genetic skin disorders. Targeting of HF
stem cells offers unique therapeutic options for genetic hair and skin therapy and
regenerative medicine.
3.2 Modifications of Hair Fiber Surface and Structure
Hair’s chemical and biological properties make it an ideal material for undergoing
an infinite number of changes and treatments, from cosmetic to clinical
applications.
Healthy and beautiful hair is desired, and the need for products that improve the
look and feel of the hair surface has created a huge industry for hair care. Products
such as shampoos and conditioners, along with damaging processes such as
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chemical dyeing and permanent wave or relaxing treatments, alter many hair
properties, which results in damage to the hair fibre [165–167]. In recent years,
many innovations have taken place, and new approaches for hair treatments have
been reported in the literature to overcome this problem.
Unaltered human hair (virgin hair) has an isoelectric point near 3.67 [168].
Hence, during a normal hair washing procedure performed at neutral pH
(pH [ pI), the surface of hair acquires negative charges. For this reason, most
conditioning shampoos possess cationic polymers in order to counteract these
negative charges, thereby improving hair texture and feel. Electrostatic interac-
tions are believed to play a crucial role in the adsorption mechanism of such
compounds [168]. However, these products are a small part of the polymer-based
cosmetic products. Polymer-containing compositions represent the second-most
common ingredient in cosmetic and personal care products. A diverse range of
polymers is applied in this segment as film formers, fixatives, rheology modifiers,
associative thickners, emulsifiers, stimuli-responsive agents, foam stabilizers and
destabilizers, beneficial skin feel agents and antimicrobials [169].
Studies on protein-based formulations to treat hair fibres have also been widely
explored. Several patents disclose compositions capable of restoring hair health by
providing excellent finishing effects. Applications of proteins such as a water-
soluble compound derived from a vegetable protein derivate [170], non-naturally
occurring keratin proteins [171], a mixture of a hydrolyzed protein and an amino
acid with an aliphatic side chain [172], and other hydrolyzed proteins [173, 174]
are also examples within this category.
Several studies have been published regarding how to improve the structure of
the keratin hair shaft mainly for cosmetic purposes. These studies take into account
the keratinous structure of hair fibres and explore the potential benefit effects of
amino acids and peptides in hair care applications [175–177]. Silva et al. [178]
described the importance of peptide structure in hair penetration using conven-
tional fluorescent microscopy. We have been investigating the protein disulfide
isomerase (PDI) for the functionalization of keratinaceous surfaces with cysteine-
containing compounds (CCC) (Fernandes et al., submitted data). PDI is a multi-
functional enzyme that catalyses formation and isomerization of disulfide bonds
(disulfide shuffling) in a wide range of substrates. In vivo, PDI promotes the
correct formation of disulfide bonds in proteins (oxidative folding), leading them
to the native state. The CCCs were shown to penetrate inside the hair shaft and
attach to the cortex without damaging hair. This approach can represent a prom-
ising strategy for the development of new hair care formulations with the ability to
dye and restore the integrity of damaged hair (Fernandes et al., submitted data).
PDI has also been used for treatment of wool [179] and hair fibres [180]. King
and Brockway [179] showed that PDI was able to restore part of the original
properties on aged or harshly treated wool. The same enzyme was used by
Brockway [180] to perform a curling, waving or straightening treatment safely
under mild condition.
A method to gently and permanently relax or straighten hair was also attained
by Presti [181] using a protease, kerA. This enzyme was found to cleave inter-
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peptide bonds, allowing the hair fiber to be relaxed or straightened with less
damage to the fiber than would have occurred using traditional or existing
straightening methods [181].
Humidity is an important factor when considering hair beauty and styling. Air
humidity affects hair form and structure at the level of hydrogen bonds. A
humidity increase of 30–70% will augment by twofold the water content of hair,
thereby increasing its volume by more than 20%. This influx of water eventually
causes the hair fibres to swell, which results in friction between fibres and an
additional increase in volume and frizz, changing hair appearance [182]. To
overcome this issue, scientists from Massachusetts Institute of Technology (MIT)
developed a technology that reduces hair frizz using a polyfluoroester, a molecule
smaller than the traditional ones used for frizz control. Because of its chemical
nature, the formulation adheres tightly to the hair, promoting long-lasting resis-
tance to moisture. Because of its low surface energy, this technology repels most
other materials like water and oils. As an additional benefit, the low refractive
index of the coating produces a unique, long-lasting shine and pop in the colour of
the hair [183].
Today, people in ever-greater numbers alter their hair colour and appearance.
However, the aggressiveness of the available techniques poses a big drawback to
hair colouring. Commonly used hair dyeing compositions are driven by a mech-
anism of diffusion of small molecules into the hair fiber [184]. There are three
different types of hair colouring agents: permanent, semi-permanent and tempo-
rary colourants. The permanent hair dyes are constituted of small dye precursors,
able to penetrate into hair, which develop the colour within the hair shaft in the
presence of high alkalinity and oxidative conditions. These dyes provide the best
colouring results, but cause significant hair damage. The semi-permanent and
temporary dyes are molecules too large to diffuse into the hair, therefore acting on
the exterior of the fiber at the cuticle. This process does not harm the fiber because
of the absence of alkaline oxidative conditions, but fails in terms of colour
durability [166]. For this reason, the development of a colouring agent that pro-
vides the durability of the permanent hair dyes without the use of oxidizing agents
that damage hair is highly desirable.
It is generally accepted that penetration of chemicals into hair occurs through
intercellular diffusion, i.e., by adsorption onto the keratin substrate. Faucher and
Goddard [185] have shown that the amount of polymer adsorbed on the hair
surface increased with decreasing molecular weight. Similarly, low molecular
weight compounds might also penetrate the hair shaft, at the cortex level, since the
diffusion process is greatly facilitated when hair is exposed to water. Low
molecular weight compounds are, however, only retained while the hair is dry
because further contact with water opens the cuticle scales, facilitating their
escaping. Recent solutions to this problem rely on the use of hair-binding peptides
coupled to dyes or pigments that are able to penetrate into the hair shaft, although
they lack the required durability for long lasting colour effects. Huang et al. [186]
have tested a hair-binding peptide coupled to carbon black and the use of chem-
ically functionalized carbon nanotubes that provided an enhanced interaction with
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the hair, resulting in a more durable hair colouring effect. Nevertheless, more
durable hair colourants are still needed.
For this reason, there have been attempts to enhance the binding of the cosmetic
agent to hair. Richardson et al. [187] describe the covalent attachment of cosmetic
agents to hair using transglutaminases. These enzymes promote the crosslinking of
the cosmetic agent’s amine to the glutamine residues in hair. Similarly, Green
et al. [188] describe the use of the enzyme lysine oxidase to covalently attach
cosmetic agents to hair.
Despite all the research for cosmetic applications, conventional products are
still being used, with small improvements. Formulation requirements imply very
strict criteria for dye/product selection. The remaining problem is achieving per-
fect compatibility in all respects between the dyes/products and the various other
constituents of the products.
4 Final Remarks
Hirsutism, graying, alopecia and other disorders of human HFs have dramatic
effects on the appearance, socio-cultural status and self-esteem of the affected
individuals. The most current treatments available are very aggressive to hair and
potentially to human health. In order to solve these problems, new and more
efficient approaches are required.
Much progress has been made in understanding the genetic basis and molecular
pathways activated during HF embryogenesis, cycling, disorders and the ageing
process. HFs are a rich source of stem cells. The recent advances in the isolation,
gene expression profile and propagation of stem cells could lead to the modulation
of these cells with therapeutic purposes in the treatment of alopecia, wounds,
burns, carcinogenesis and even ageing.
The potential specific targeting of different HF-associated cells, namely DP and
immune cells, by bioactive compounds, along with effective follicular delivery
systems will allow the development of home-based procedures for the mainte-
nance and treatment of hair and scalp disorders.
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